+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cisplatin"

From
Cervical Cancer Treatment - A Global Market Overview - Product Thumbnail Image

Cervical Cancer Treatment - A Global Market Overview

  • Report
  • November 2024
  • 250 Pages
  • Global
From
From
From
Pemetrexed + cisplatin Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Pemetrexed + cisplatin Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
IMFINZI Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

IMFINZI Emerging Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
Ipilimumab + nivolumab Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Ipilimumab + nivolumab Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
From
US Glioma - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

US Glioma - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • April 2023
  • 200 Pages
  • United States
From
Extensive-Stage Small Cell Lung Cancer (ESCLC) - Pipeline Insight, 2025 - Product Thumbnail Image

Extensive-Stage Small Cell Lung Cancer (ESCLC) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Advanced Urothelial Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Urothelial Carcinoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Metastatic Urothelial Carcinoma- Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Urothelial Carcinoma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 150 Pages
  • Global
From
Metastatic Triple-Negative Breast Cancer (mTNBC)- Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Triple-Negative Breast Cancer (mTNBC)- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Gemcitabine HCL Market Report and Forecast 2023-2031 - Product Thumbnail Image

Gemcitabine HCL Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 147 Pages
  • Global
From
From
Ovarian Cancer Pipeline Analysis Report - Product Thumbnail Image

Ovarian Cancer Pipeline Analysis Report

  • Report
  • August 2024
  • 150 Pages
  • Global
From
Loading Indicator

Cisplatin is a chemotherapy drug used to treat a variety of cancers, including lung cancer. It works by damaging the DNA of cancer cells, preventing them from growing and dividing. Cisplatin is often used in combination with other drugs to increase its effectiveness. It is administered intravenously and can cause side effects such as nausea, vomiting, and hair loss. The market for cisplatin in the treatment of lung cancer is highly competitive, with many companies offering their own versions of the drug. Companies such as Bristol-Myers Squibb, Pfizer, and Merck & Co. are all major players in the market. Other companies, such as Teva Pharmaceuticals and Mylan, also offer generic versions of the drug. In the market for cisplatin, companies such as Bristol-Myers Squibb, Pfizer, Merck & Co., Teva Pharmaceuticals, and Mylan are all major players. Show Less Read more